NCT04139304 2025-06-29A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaAIDS Malignancy ConsortiumPhase EARLY_PHASE1 Recruiting15 enrolled
NCT01184885 2025-05-04A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyThomas Jefferson UniversityPhase EARLY_PHASE1 Completed7 enrolled 8 charts